HK1047593A1 - 抗血栓形成的化合物 - Google Patents
抗血栓形成的化合物Info
- Publication number
- HK1047593A1 HK1047593A1 HK02109170.1A HK02109170A HK1047593A1 HK 1047593 A1 HK1047593 A1 HK 1047593A1 HK 02109170 A HK02109170 A HK 02109170A HK 1047593 A1 HK1047593 A1 HK 1047593A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- antithrombotic compound
- antithrombotic
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99204172 | 1999-12-07 | ||
PCT/EP2000/012155 WO2001042262A2 (en) | 1999-12-07 | 2000-12-01 | Antithrombotic compound |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1047593A1 true HK1047593A1 (zh) | 2003-02-28 |
Family
ID=8240976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02109170.1A HK1047593A1 (zh) | 1999-12-07 | 2002-12-18 | 抗血栓形成的化合物 |
Country Status (23)
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1558911B (zh) * | 2001-09-07 | 2010-05-12 | 阿尔开密亚有限公司 | 合成肝素五糖 |
DE60330485D1 (de) | 2002-07-15 | 2010-01-21 | Merck & Co Inc | Zur behandlung von diabetes |
CA2499586A1 (en) | 2002-10-07 | 2004-04-22 | Merck & Co., Inc. | Antidiabetic beta-amino heterocyclic dipeptidyl peptidase inhibitors |
BR0315796A (pt) | 2002-11-07 | 2005-09-13 | Merck & Co Inc | Composto, composição farmacêutica, e, métodos para tratar diabetes, para tratar hiperglicemia, e para tratar obesidade em um mamìfero |
JP4564952B2 (ja) | 2003-01-17 | 2010-10-20 | メルク・シャープ・エンド・ドーム・コーポレイション | 糖尿病の治療および予防のためのジペプチジルペプチダーゼ阻害薬としての3−アミノ−4−フェニルブタン酸誘導体 |
CA2513684A1 (en) | 2003-01-31 | 2004-08-19 | Merck & Co., Inc. | 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
US7560455B2 (en) | 2003-05-14 | 2009-07-14 | Merck & Co., Inc. | 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
CN1798556A (zh) | 2003-06-06 | 2006-07-05 | 麦克公司 | 作为治疗或者预防糖尿病的二肽基肽酶抑制剂的稠合吲哚 |
EP1638950A4 (en) | 2003-06-17 | 2010-06-30 | Merck Sharp & Dohme | CYCLOHEXYLGLYCIN DERIVATIVES AS INHIBITORS OF DIPEPTIDYL PEPTIDASE FOR THE TREATMENT OR PREVENTION OF DIABETES |
CA2533893A1 (en) | 2003-07-31 | 2005-02-10 | Merck & Co., Inc. | Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
EP1574516A1 (en) | 2004-03-05 | 2005-09-14 | Sanofi-Aventis | Antithrombotic compound |
TW200621794A (en) * | 2004-10-06 | 2006-07-01 | Akzo Nobel Nv | Pulmonary administration of an antithrombotic compound |
TWI403334B (zh) * | 2004-12-23 | 2013-08-01 | Merck Sharp & Dohme | 包含生物素殘基之抗血栓雙重抑制劑 |
TWI376234B (en) | 2005-02-01 | 2012-11-11 | Msd Oss Bv | Conjugates of a polypeptide and an oligosaccharide |
RU2434876C2 (ru) * | 2005-10-10 | 2011-11-27 | Н.В. Органон | Антитромботические двойные ингибиторы, включающие биотиновую метку |
AU2010332797B2 (en) | 2009-12-18 | 2015-05-28 | Catalent Pharma Solutions Gmbh | Pharmaceutical oral dosage form containing a synthetic oligosaccharide |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4115468A1 (de) * | 1991-05-11 | 1992-11-12 | Behringwerke Ag | Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien |
DE4206858A1 (de) * | 1992-03-05 | 1993-09-09 | Behringwerke Ag | Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel |
NZ264340A (en) * | 1993-09-01 | 1995-04-27 | Akzo Nobel Nv | Bisconjugate comprising two saccharides and a spacer, use in pharmaceutical compositions |
IL126893A (en) * | 1997-11-19 | 2003-05-29 | Akzo Nobel Nv | Sulfated pentasaccharide derivatives and pharmaceutical compositions containing them |
US6486129B1 (en) * | 1998-06-17 | 2002-11-26 | Akzo Nobel N.V. | Antithrombotic compounds |
-
2000
- 2000-11-21 TW TW089124693A patent/TWI289566B/zh not_active IP Right Cessation
- 2000-12-01 CZ CZ20021958A patent/CZ303385B6/cs not_active IP Right Cessation
- 2000-12-01 WO PCT/EP2000/012155 patent/WO2001042262A2/en active Search and Examination
- 2000-12-01 HU HU0203471A patent/HUP0203471A3/hu unknown
- 2000-12-01 KR KR1020027007186A patent/KR100776607B1/ko not_active IP Right Cessation
- 2000-12-01 NZ NZ519100A patent/NZ519100A/en not_active IP Right Cessation
- 2000-12-01 EP EP00983209.8A patent/EP1237897B1/en not_active Expired - Lifetime
- 2000-12-01 RU RU2002118117/04A patent/RU2266913C2/ru not_active IP Right Cessation
- 2000-12-01 IL IL14962800A patent/IL149628A0/xx unknown
- 2000-12-01 CN CNB008167753A patent/CN1195767C/zh not_active Expired - Fee Related
- 2000-12-01 BR BR0016217-5A patent/BR0016217A/pt active Search and Examination
- 2000-12-01 PL PL355484A patent/PL202840B1/pl not_active IP Right Cessation
- 2000-12-01 US US10/148,868 patent/US6875755B2/en not_active Expired - Lifetime
- 2000-12-01 JP JP2001543559A patent/JP4820517B2/ja not_active Expired - Lifetime
- 2000-12-01 SK SK794-2002A patent/SK287682B6/sk not_active IP Right Cessation
- 2000-12-01 CA CA2393042A patent/CA2393042C/en not_active Expired - Lifetime
- 2000-12-01 AU AU20038/01A patent/AU781846B2/en not_active Expired
- 2000-12-06 AR ARP000106443A patent/AR026726A1/es active IP Right Grant
- 2000-12-06 PE PE2000001308A patent/PE20010935A1/es not_active Application Discontinuation
- 2000-12-06 CO CO00093231A patent/CO5251449A1/es not_active Application Discontinuation
-
2002
- 2002-05-13 ZA ZA200203799A patent/ZA200203799B/xx unknown
- 2002-05-14 IL IL149628A patent/IL149628A/en not_active IP Right Cessation
- 2002-06-06 NO NO20022689A patent/NO323059B1/no not_active IP Right Cessation
- 2002-12-18 HK HK02109170.1A patent/HK1047593A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2357761B (en) | Compounds | |
IL149628A0 (en) | Antithrombotic compound | |
HK1034266A1 (en) | Antithrombotic compounds | |
GB9924797D0 (en) | Compound | |
GB9920919D0 (en) | Novel compound | |
GB9902399D0 (en) | Compounds | |
GB9921928D0 (en) | Compound | |
GB0031563D0 (en) | Compound | |
GB0031557D0 (en) | Compound | |
GB9914342D0 (en) | Compound | |
GB9929255D0 (en) | Compound | |
GB9921929D0 (en) | Compound | |
PL353370A1 (en) | Novel compound f-15078 | |
GB9924965D0 (en) | Compound | |
GB9926160D0 (en) | Antithrombotic agents | |
GB9915436D0 (en) | Compound | |
GB9917377D0 (en) | Compound | |
GB9929445D0 (en) | Compound | |
PL332995A1 (en) | Antithrombotic agent | |
GB9902935D0 (en) | Novel compound | |
GB9905415D0 (en) | Novel compound | |
GB9903239D0 (en) | Compounds | |
GB9901423D0 (en) | Compounds | |
GB9903272D0 (en) | Compounds | |
GB9903269D0 (en) | Compounds |